Cannabis Report
Home > Boards > Canadian > Biotechs >

Pediapharm

RSS Feed
Add Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 7/18/2016 10:26:40 AM - Followers: 2 - Board type: Free - Posts Today: 0



This Undiscovered Company has 6 Drugs on Market and 5 under review by Health Canada . The Game Changer for Pediapharm is Easyhaler which expected to approved before year end .Another reason to own the Stock is the upcoming US-Partnership for Naproxen which also expected before year end . This Stock is a Lifetime Opportunity .



Pediapharm (PDP)

MarketCap: C$ 22.2 Millionen
Cash: $5.5 Millionen

Price: $0.31


Nice Summary (Fact Sheet)
http://www.pedia-pharm.com/wp-content/themes/ifeature-tpl/PDF/PDP_Fact_sheet_oct_26_2015.pdf



Pediapharm has submitted its reconsideration package to Health Canada regarding Easyhaler Budesonide. The Company’s objective remains to obtain a marketing approval by the end of 2015.


Furthermore, before the end of 2015, the Company intends to sign an agreement with a US commercial partner for the selling and marketing of its first product acquisition in the US; namely the Pediapharm Naproxen Suspension. Pediapharm believes that with this agreement, the Company will reach profitability more rapidly.
Cannabis Report
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#5   Great News BioSpecialist 07/18/16 10:26:40 AM
#4   2 Approvals around the corner = 300-500% upside BioSpecialist 07/13/16 11:27:17 AM
#3   The Company is close to profitability and with BioSpecialist 11/14/15 03:56:42 AM
#2   PDP: 14M curr peak (not actual) sales + seventhwave 11/13/15 04:18:44 PM
#1   This Undiscovered Company has 6 Drugs on Market BioSpecialist 11/13/15 01:39:02 PM
PostSubject